Bicycle Therapeutics (BCYC) Receivables - Net (2019 - 2025)

Bicycle Therapeutics (BCYC) has 7 years of Receivables - Net data on file, last reported at $136000.0 in Q1 2025.

• For the quarter ending Q1 2025, Receivables - Net changed N/A year-over-year to $136000.0; the trailing twelve-month figure through Mar 2025 stood at $136000.0 (changed N/A YoY), and the FY2022 full-year result was $2.0 million, up 104.5% from the prior year.
• Receivables - Net for Q1 2025 stood at $136000.0, down from $233000.0 in the prior quarter.
• Across five years, Receivables - Net topped out at $50.0 million in Q1 2023 and bottomed at $136000.0 in Q1 2025.
• The 5-year median for Receivables - Net is $2.0 million (2022), against an average of $12.5 million.
• The widest annual swing landed in 2023, when Receivables - Net surged 2073.91%; it then tumbled 99.48% in 2024.
• A 5-year view of Receivables - Net shows it stood at $1.0 million in 2021, then surged by 104.5% to $2.0 million in 2022, then soared by 2104.89% to $45.1 million in 2023, then sank by 99.48% to $233000.0 in 2024, then slumped by 41.63% to $136000.0 in 2025.
• The last three Receivables - Net figures came in at $136000.0 (Q1 2025), $233000.0 (Q2 2024), and $45.1 million (Q2 2023), per Business Quant data.

Peer Comparison